HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short-term outcome of Boston Type 1 keratoprosthesis for bilateral limbal stem cell deficiency.

Abstract
This study reports the short-term functional and anatomical outcome of Boston Type 1 keratoprosthesis (Boston Kpro) implantation for bilateral limbal stem cell deficiency (LCSD). Retrospective analysis was done on eight eyes of eight patients who underwent Boston Kpro implantation between July 2009 and October 2009. The best corrected visual acuity (BCVA) and slit-lamp biomicroscopy findings were assessed at 1, 3 and 6 months postoperatively. All eight eyes retained the prosthesis. BCVA of 20/40 or better was achieved in 8, 6, and 5 eyes at 1, 3, and 6 months, respectively, postoperatively. One patient each developed epithelial defect, sterile stromal melt and fungal keratitis in the late postoperative period associated with antecedent loss of the soft contact lens from the eye. Boston Kpro has good short-term visual and anatomical outcome in patients with bilateral LSCD, provided compliance with postoperative care can be ensured.
AuthorsSayan Basu, Mukesh Taneja, Raja Narayanan, Sirisha Senthil, Virender S Sangwan
JournalIndian journal of ophthalmology (Indian J Ophthalmol) 2012 Mar-Apr Vol. 60 Issue 2 Pg. 151-3 ISSN: 1998-3689 [Electronic] India
PMID22446917 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Adult
  • Blindness (etiology, surgery)
  • Corneal Diseases (complications, pathology, surgery)
  • Follow-Up Studies
  • Humans
  • Limbus Corneae (pathology)
  • Middle Aged
  • Prostheses and Implants
  • Retrospective Studies
  • Stem Cells (pathology)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: